
|Videos|October 1, 2015
Your BRCA Gene Test Results
Advertisement
Advertisement
Related to this article

FDA approves Inluriyo plus Verzenio for adults with ESR1-mutated, ER-positive, HER2-negative advanced or metastatic breast cancer after endocrine therapy.

A phase 1 trial treated 15 patients with breast cancer that spread to the spinal fluid using a vaccine made from their own immune cells. One patient is now more than three years from diagnosis.
Advertisement
Advertisement
Trending on CURE
1
5 Years of Leukemia Advances: A Timeline of FDA Approvals and What They Mean for Patients
2
Blood Cancer Treatments in the FDA Pipeline: What Could Come Next
3
FDA Approves Inluriyo Plus Verzenio for Certain Advanced Breast Cancers
4
Childhood Leukemia Survivor Shares Her Experience With ALL, Relapse and CAR-T
5








